XNCR
Xencor Inc
Clinical-stage biopharmaceutical company developing engineered antibody therapeutics for cancer, autoimmune and allergic diseases
CUSIP: 98401F105HealthcareUS1 holder
Total Value
$1.17M
Total Shares
51.0K
Net Share Change
-107.0K
Activity
1 selling
Investor
Value
Shares
Weight
Change
Maverick Capital
$1.17M51.0K shares
TRIM-107.0K(-67.7%)